Results 81 to 90 of about 27,178 (263)

Allergic conjunctivitis and the most common allergens in Northern Greece

World Allergy Organization Journal, 2013
Background Ocular allergies affect a great part of the general population and often co exist with other allergic manifestations. In the present study, the prevalence of allergic conjunctivitis and the commonest allergens in allergic patients at an ...
Diamantis Almaliotis, Pavlos Michailopoulos, Dimitrios Gioulekas, Paschalina Giouleka, Despina Papakosta, Thomas Siempis, Vasileios Karampatakis   +6 more
doaj  

Immediate-Type Hypersensitivity to Succinylated Corticosteroids [PDF]

, 2011
Background: Despite their frequent use, systemic corticosteroids have rarely elicited immediate-type reactions. Objective: We report two male patients, aged 26 and 70 years, respectively, with severe immediate-type hypersensitivity secondary to the ...
Przybilla, Bernhard, Raewer, Helen-Caroline, Sieber, Wolfgang, Walker, Annett Isabel   +3 more
core   +1 more source

IgE Sensitization to Inhalant Allergens and Its Association with Allergic Diseases in Adults

Iranian Journal of Allergy, Asthma and Immunology, 2018
Allergic sensitization to inhalant allergens could be considered as a predictor in allergic diseases. The objective of this study was to assess IgE-mediated sensitization to inhalant allergens in allergic and non-allergic adults as well as the evaluation
Raheleh Shokouhi Shoormasti, Mohammad Reza Fazlollahi, Anoshirvan Kazemnejad, Behnoosh Tayebi, Fatemeh Nadali, Maryam Sharif Shoushtari, Shamim Khandan Alamdari, Majid Moslemi, Masoud Movehdi, Adriano Mari, Zahra Pourpak, Mostafa Moin   +11 more
doaj  

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source

Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010 [PDF]

, 2010
The Eyjafjallajökull volcano in Iceland erupted on 14 April 2010 emitting a volcanic ash plume that spread across the United Kingdom and mainland Europe.
Catchpole, M., Elliott, A.J., Harcourt, S., Ibbotson, S., Kavanagh, K., Kibble, A., Loveridge, P., McCloskey, B., McMenamin, J., Murray, V., Pnaiser, R., Ramsay, C.N., Robertson, C., Singh, N., Smith, G.E., Smith, S.   +15 more
core  

Altered hyaluronic acid content in tear fluid of patients with adenoviral conjunctivitis

Anais da Academia Brasileira de Ciências, 2015
The adenoviral conjunctivitis is one of the biggest causes of conjunctival infection in the world. Conjunctivitis causes relatively nonspecific symptoms, as hyperaemia and chemosis.
JULIANA L. DREYFUSS, CAIO V. REGATIERI, BRUNO COELHO, JOSÉ B. BARBOSA, DENISE DE FREITAS, HELENA B. NADER, JOÃO R. MARTINS   +6 more
doaj   +1 more source

Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This cohort study of 1793 atopic dermatitis patients (aged ≥ 12) found higher infection rates with Janus kinase inhibitor treatment compared to biologic treatment, particularly for herpes infections, with a history of viral or fungal skin infection as a risk factor associated with infection.
Lian F. van der Gang, Keneshka Atash, Nicolaas P. A. Zuithoff, Inge Haeck, Celeste M. Boesjes, Octavian I. Bacoş‐Cosma, Laura Loman, Marijke Kamsteeg, Simone Stadhouders‐Keet, Albert J. Oosting, Anneke M. T. van Lynden‐van Nes, Klaziena Politiek, Antoni Gostynksi, Lisette Berntsen‐Zandbergen, Wianda A. Christoffers, Annebeth Flinterman, Wouter R. H. Touwslager, Berit Velstra, Shiarra M. Stewart, Francine C. van Erp, Marlies de Graaf, Marie‐Louise A. Schuttelaar, Marjolein S. de Bruin‐Weller   +22 more
wiley   +1 more source

Assessing the painful, uninflamed eye in primary care [PDF]

, 2015
We acknowledge the important contributions of Professor Amada J Lee, University of Aberdeen, Division of Statistics, for assistance with analysing the data from the patient survey.
Dick, Andrew, Forrester, John V., Kuffova, Lucia   +2 more
core   +1 more source

Apafant, a Potent Platelet-Activating Factor Antagonist, Blocks Eosinophil Activation and Is Effective in the Chronic Phase of Experimental Allergic Conjunctivitis in Guinea Pigs

Journal of Pharmacological Sciences, 2004
Platelet-activating factor (PAF) plays important roles in allergic reactions. In particular, there are many concerns about PAF, eosinophils, and the chronicity of allergic diseases.
Masatomo Kato, Kenji Imoto, Hideki Miyake, Tomoko Oda, Suguru Miyaji, Masatsugu Nakamura   +5 more
doaj  

Optimizing the treatment for dry eye syndrome in patients with allergic conjunctivitis

Journal of Ophthalmology, 2020
Background: Allergic conjunctivitis is commonly complicated by secondary dry eye syndrome that substantially affects the quality of life of patients and requires a comprehensive approach to treatment.
F.A. Bakhritdinova, S.A. Mirrakhimova, K.I. Narzikulova, Zh.O. Safarov, O.I. Oripov   +4 more
doaj   +1 more source